Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 生物科技系(所) > 期刊論文 > Item 310902800/34557

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34557

標題:	Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression
作者:	Chan, Ti-Chun Hsing, Chung-Hsi Shiue, Yow-Ling Huang, Steven K. Hsieh, Kun-Lin Kuo, Yu-Hsuan Li, Chien-Feng
貢獻者:	Chi Mei Hospital National Health Research Institutes - Taiwan National Sun Yat Sen University Department of Biotechnology, Chia Nan University of Pharmacy & Science College of Pharmacy and Science, Chia Nan University of Pharmacy & Science
關鍵字:	endothelial growth-factor targeted therapy c/ebp-delta cancer bevacizumab inhibition resistance cisplatin vegfa
日期:	2022
上傳時間:	2023-12-11 13:57:44 (UTC+8)
出版者:	MDPI
摘要:	Background and Purpose: This research aimed to excavate the alternative mechanism of CEBPD on tumor growth and explore the biological significance of the CEBPD/hsa-miR-429/VEGFA axis on angiogenesis in urothelial carcinoma (UC). Methods: Quantitative RT-PCR, immunoblotting assay and tube formation examined the effect of hsa-miR-429 mimic or/and inhibitor on VEGFA expression and angiogenesis in CEBPD-overexpressing UC-derived cells. The association between CEBPD, hsa-miR-429, VEGFA and microvascular density (MVD) and clinical outcome were evaluated in 296 patients with UBUC and 340 patients with UTUC, respectively. Results: The increase in the transcript and protein of VEGFA as well as HUVECs tube formation was diminished upon the treatment of hsa-miR-429 mimic in CEBPD-overexpressing BFTC909 and TCCSUP. Nevertheless, the inhibited regulation of hsa-miR-429 mimic on the expression of VEGFA and ability of HUVECs tube formation was rescued by the combined incubation with hsa-miR-429 inhibitor in these two UC-derived cell lines. Furthermore, the clinical correlations showed that the higher level of VEGFA or MVD has a positive correlation with the expression of CEBPD and a negative relation to hsa-miR-429 and leads to tumor aggressiveness with worse disease-specific, metastasis-free survival in UBUC and UTUC cohorts. Conclusions: We decipher the oncogenic mechanism of CEBPD on angiogenesis through the hsa-miR-429 inhibition to stabilize the expression of VEGFA in UC. The novel research unveiled the modulation of the CEBPD/hsa-miR-429/VEGFA axis on the progression of UC and could be accessible to theranostic biomarkers.
關聯:	CELLS, v.11, n.4, 638
顯示於類別:	[生物科技系(所)] 期刊論文 [化妝品應用與管理系(所)] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
cells-11-00638-v2.pdf		2569Kb	Adobe PDF	106	檢視/開啟
index.html		0Kb	HTML	204	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....